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Abstract
Purpose of Review Nursing home residents are at high risk for
colonization and infection with bacterial pathogens that are
multidrug-resistant organisms (MDROs). We discuss chal-
lenges and potential solutions to support implementing effec-
tive infection prevention and control practices in nursing
homes.
Recent Findings Challenges include a paucity of evidence
that addresses MDRO transmission during the care of nursing
home residents, limited staff resources in nursing homes, in-
sufficient infection prevention education in nursing homes,
and perceptions by nursing home staff that isolation and
contact precautions negatively influence the well being of
their residents.
Summary A small number of studies provide evidence that
specifically address these challenges. Their outcomes support
a paradigm shift that moves infection prevention and control
practices away from a pathogen-specific approach and toward
one that focuses on resident risk factors.
Keywords Nursing home . Infection prevention and control .
Methicillin-resistant Staphylococcus aureus .
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Introduction
Preventing healthcare-associated infections (HAI) and im-
proving safety for residents in nursing home settings, which
provide both post-acute skilled nursing and rehabilitation as
well as long-term residential care, is a national priority [1].
Frail and older adults receiving care in nursing homes are at
higher risk of infections due to age-related immune senes-
cence, accumulation of comorbid conditions, and a higher
burden of functional and cognitive deficits that increase de-
pendence on caregivers. Additionally, the social and interac-
tive nature of nursing homes such as shared dining, recreation,
and therapeutic facilities generates opportunities for commu-
nicable diseases to spread.
The prevalence of risk factors for acquiring multidrug-
resistant organisms (MDROs) and Clostridium difficile
among nursing home residents has also increased with the
growing complexity of medical care delivered in these set-
tings. The post-acute, short stay population frequently requires
invasive medical devices (e.g., urinary and vascular catheters)
[2], wound management, and experiences more frequent
healthcare and antibiotic exposure, all of which contribute to
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the emergence and spread of resistant pathogens. Here, we
focus on recent evidence that supports integrating resident risk
factors, such as the presence of indwelling catheters and
gastrostomy tubes, into comprehensive infection prevention
and control strategies to reduce MDRO transmission and
acquisition.
Prevalence of Healthcare-Associated Infections
in Nursing Homes
Few studies have described the prevalence of HAI in nursing
homes across the USA. Based on single facilities or clusters of
facilities, Strausbaugh and Joseph estimated that 1.6 million to
3.8 million infections occur each year in the nursing homes,
with a range of 1.8–13.5 infection per 1000 resident days [3].
A national point prevalence survey reported that in 2004, 12%
of residents had an infection acquired either during a recent
hospitalization or at a nursing home [4]. The Department of
Veterans Affairs (VA) reported that in 2005 and 2007, the
prevalence of infections among residents of VA nursing
homes, termed community living centers (CLCs), was 5%
[5]. Notably, for residents with indwelling devices, the rate
was nearly 11%. Urinary catheters and gastrostomy tubes
were the most common devices but more recently the preva-
lence of intravascular catheters has increased due to higher
number of nursing homes providing post-acute infusion-relat-
ed services [2]. A point prevalence study including several
European countries reported that in 2013, 3.4% of nursing
home residents had an HAI, with the prevalence rate in indi-
vidual countries ranging from 0.4 to 7% [6].
Infection, Colonization, and Risk Factors
for Multidrug-Resistant Organisms and C. difficile
The rate of MDRO infections among nursing residents is not
well described. Kahvecioglu et al. examined this using the
Centers for Medicaid & Medicare Services Long Term Care
Minimum Data Set (MDS), a standardized assessment tool
that is implemented on admission to the nursing home and
quarterly thereafter [7]. They found a rate of MDRO infec-
tions of 4.2% among nursing home residents across the USA,
with a range from 1.9 to 11.4% among individual states.
Several studies describe that colonization with MDROs is
common in the nursing home population. The rate of
methicillin-resistant Staphylococcus aureus (MRSA) coloni-
zation among NH residents may exceed 50% [8, 9], far greater
than the rate of 5–10% among hospitalized patients [10, 11].
While the prevalence of vancomycin-resistant Enterococcus
(VRE) ranges from 4 to 16% [12, 13], the prevalence of
multidrug-resistant Gram-negative bacilli is increasing [14].
Some studies found that approximately 50% of NH residents
are colonized with quinolone-resistant Gram-negative bacilli
compared to 17 and 1% colonization with extended-spectrum
β-lactamase (ESBL)–producing and carbapenem-resistant
Enterobacteriaceae (CRE), respectively [12, 13, 15–18].
Recent antibiotic exposure (within 4months) correlatedwith
an over fivefold increased risk of colonization with a drug-
resistant Gram-negative bacilli [19] and with acquisition of
MRSA [8, 20]. Additionally, dependence upon assistance with
activities of daily living (ADLs) increased the risk of acquiring
anMDRO. In a study of 82 nursing home residents, Fisch et al.
found that most residents (53 to 71%) became colonized with
MDROs after admission to the nursing home and reported a
higher rate of functional dependence among those that became
colonized compared to those that did not [12]. The time to
acquisition varied based on the bacteria, ranging from an aver-
age of 186 days (±108 days) for VRE and 127 days (±79 days)
for MRSA to just 76 days (±66 days) for ciprofloxacin-resistant
Gram-negative bacilli. The median length of stay in long-term
care facilities is 463 days [21]. Other risk factors for coloniza-
tion with MDRO include the presence of indwelling medical
devices, decubitus ulcers, presence of wounds, and urinary and
fecal incontinence [8, 13, 22, 23].
In the last 10 years, colonization with C. difficile of
NH residents ranged from 4 to 50% and a recent meta-
analysis that included reports from Canada, Germany,
and Ireland reported a pooled mean of 15% [24–26].
Compared with MDRO infections, more robust data is
available for the rates and impact of C. difficile infec-
tion among nursing home residents. Campbell et al. de-
termined the incidence rates in Ohio nursing homes to
be 1.7–2.9 per 10,000 residents-days in 2006 [27],
which is similar to the 2.3 per 10,000 residents-days
(interquartile range [IQR], 1.2–3.3) rate reported in
nursing homes in Monroe County, NY in 2010 [28].
Hunter et al. used a population-based surveillance ap-
proach to estimate that the rate of nursing home onset
C. difficile infection in the USA for 2012 was over
110,000 cases [29]. Over 25% of those individuals re-
quired hospitalization, nearly 20% had a recurrence and
8% died. These data support the concern that C. difficile
is endemic in some long-term care settings [30].
Recognized risk factors for C. difficile carriage among
nursing home residents include a previous history of C.
difficile infection, antibiotic use in the prior 3 months, and
recent hospitalization [25, 26]. Furthermore, following treat-
ment for C. difficile infection, residents continue to shed
spores onto their skin where they may contaminate the hands
of health care personnel [25, 31]. Finally, asymptomatic car-
riers also shed C. difficile spores into the environment for 1 to
4 weeks after therapy, where they may remain viable for at
least 5 months on environmental surfaces [25, 32]. Both nurs-
ing home residents and their environment may serve as reser-
voirs for C. difficile spores.
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Nursing Homes as Regional Reservoirs
for Multidrug-Resistant Organisms and C. difficile
The growing prevalence of MDROs in nursing homes has
impact on regional efforts to prevent the spread of resistant
pathogens. Kahvecioglu et al. found that among nursing home
residents who became infected with an MDRO, 57% became
positive in nursing homes and 41% in acute care settings.
Such data supports consideration of regional approaches to
infection prevention and control [7]. Two independent studies
of the genetic heterogeneity ofMRSA strains in regional nurs-
ing homes and hospitals reached similar conclusions [33•, 34].
Similarly, several epidemiological investigations of
carbapenem-resistant Gram-negative bacteria also highlight
the interconnectedness of acute care hospitals and post-acute
and long-term care settings, including nursing homes. Perez
et al. studied the epidemiology of carbapenem-resistant
Acinetobacter baumannii and Klebsiella pneumoniae strains
in Northeast Ohio, finding two predominant genotypes of
each species among patients at three regional hospitals and
one long-term acute care facility [35]. Similar case clusters
of CRE occurred in West Virginia and in four adjacent
counties in Indiana and Illinois with a single nursing home
and long-term acute care facility, respectively, identified as
playing an important role in transmission [36, 37]. More re-
cently, serial surveillance cultures of residents with advanced
dementia revealed transmission of multidrug-resistant Gram-
negative bacteria among residents as well as between 22 nurs-
ing homes near Boston, Massachusetts [38•].
Just as the burden and transmission of an MDRO in
one setting may affect regional healthcare, efforts to re-
duce MDRO colonization in one setting has the potential
to reduce the risk of MDRO infections in other institu-
tions. Simulation models based on data from Orange
County, California suggest that improving infection pre-
vention and control practices may have regional benefits.
Lee et al. reported outcomes from a modeling study in-
dicating that contact precautions for nursing home resi-
dents colonized for MRSA, with a 50% adherence rate,
might reduce the prevalence of MRSA by 14% in nurs-
ing home settings and 2% in hospital settings [39].
Further modeling of universal MRSA decolonization of
ICU residents projected a 3.0 and 1.9% reduction in the
prevalence of MRSA colonization in long-term acute-
care and nursing homes, respectively [40].
Overall, while the rates of new-onset C. difficile infection
are higher for hospitalized patients, the larger number of nurs-
ing home beds means that the disease burden is greater among
the long-term care population as a whole [27, 28]. The period
of highest risk for infection is within 5 weeks of admission,
likely reflecting vulnerability induced by antibiotic exposure
during hospitalization coupled with exposure to spores in the
nursing home [28, 29, 41].
Challenges to Implementing MDRO Prevention
in Nursing Homes
Several authoritative and academic health organizations have
issued guidelines addressing infection prevention and control
for MDROs in nursing homes [42–46]. The intent of the
guidelines is to provide structure and function for establishing
infection control programs in nursing homes. Studies in long-
term care settings are limited and unfortunately, most of the
recommendations are based primarily on evidence extrapolat-
ed from acute care settings. This discord highlights several
challenges to infection prevention and control in nursing
homes.
First, at the time guidelines on MDRO prevention and
transmission-based precautions were written, there was a lack
of evidence about effective infection prevention and control
strategies in nursing homes. As described by Uchida et al. in a
systemic review of randomized and non-randomized studies,
the available evidence supporting infection prevention and
control interventions in long-term care is limited, with a num-
ber of inconsistencies in implementation and significant
knowledge gaps among staff [47]. In the USA, guidelines
regarding isolation policies suggest that decisions regarding
placing residents with MDRO colonization or infection on
contact precautions should be made on a case-by-case basis
[44]. Specific considerations include the impact on the social
and psychological health of the residents as well as the risk for
cross-transmission within the facility. Federal regulations re-
quire facilities to obtain permission from residents in order to
move rooms, which favors the preferences of individual resi-
dents over the infection prevention and control practices that
attempt to consider the safety of all residents. Ultimately, the
decision to isolate, cohort or use contact precautions for a
resident is left up to the nursing home staff, which is influ-
enced by the availability of private rooms and the preference
of residents and their families. Furthermore, most of the evi-
dence nursing homes might use to guide those decisions is
adapted from infection prevention and control strategies de-
veloped and validated in hospitals.
Second, compared to acute care facilities which are replete
with on-site physicians, nurses, pharmacists, and robust infra-
structure to support diagnostic testing, nursing homes are
resource-limited settings. Very few nursing homes have in-
house laboratories and most must contract with outside ven-
dors for laboratory and radiology services. This often means
that nursing homes cannot make use of advanced microbio-
logical and serological tests due to limited access or prohibi-
tive costs. Even the simple act of obtaining a chest radiograph
or routine laboratory tests takes longer in nursing home set-
tings and may sometimes require transfer to an emergency
department. Accordingly, nursing home providers face diag-
nostic uncertainty due to lack of onsite medical providers and
delays in the availability of test results. These factors, often
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combined with difficulty in communication of symptoms by
residents with cognitive or hearing impairment, all contribute
to overtreatment with antibiotics, which in turn increases the
risk of colonization with MDROs and C. difficile infection
[11, 12]. Furthermore, most nursing homes do not perform
active surveillance cultures, which can be cost-prohibitive
[48]. Rather, they identify residents colonized with an
MDRO based on clinical cultures or based upon communica-
tions about MDRO history from the transferring facility dur-
ing care transitions, which may be limited, inaccurate, or non-
existent. This practice, while understandable, likely underes-
timates the true prevalence of MDROs among nursing home
residents [15, 49–51].
A third challenge is that nursing homes may not allocate
sufficient personnel resources or education to support effec-
tive infection prevention and control, despite increasing num-
bers of more medically complex residents with greater risk for
MDRO acquisition. Several studies reported that the role of
infection preventionist is often filled by a nurse with both
inadequate training and time to carry out those duties. In their
national survey, Ye et al. found that only 25% of nursing
homes had a full-time infection control professional [48]. A
national survey conducted by Herzig et al. reported that over
50% of the people responsible for infection prevention and
control had at least two other roles and over 60% had no
specific training for this role [52]. Additionally, instability in
nursing home staffing may influence the prevalence of
MDROs, and thus the risk of residents becoming colonized.
Certified nursing assistants (CNAs), who comprise the bulk of
front line staff, perform a variety of tasks involving direct
resident care which, if not performed correctly, may increase
the risk of transmitting MDROs [53]. High rates of CNA
turnover correlate with increased risk of several adverse out-
comes. Furthermore, nursing homes often rely upon a mix of
permanent employees as well as temporary personnel
employed through staffing agencies. The transient nature of
agency employees also undermines efforts to educate
healthcare workers about infection prevention and control
[53]. Fortunately, strategies to reduce staff turnover and im-
prove education can be effective, as demonstrated in a study of
VA CLCs where the risk of infection among residents de-
creased as the tenure of nurses increased [54]. Furthermore,
nursing homes in states that require more than the federal
minimum for clinical education for CNAs (16 h annually)
had improved resident outcomes compare to those that did
not [55].
The final challenge is cultural and rooted in the perceptions
of nursing home staff about the influence of isolation and
contact precautions on the welfare of their residents. The over-
arching goal of nursing homes is to offer supportive care and
restorative services in an environment that respects their resi-
dents’ dignity, wellness, and quality of life. The use of the
term residents, rather than patients, communicates that
nursing homes are culturally distinct from acute care. The care
of a resident colonized or infected with an MDRO creates a
strain as nursing homes must consider the safety of other res-
idents by minimizing their exposure to potential pathogens
[56]. Furuno et al. explored the opinions of nursing home staff
about isolation precautions for nursing home residents with
MRSA or VRE [57]. They found that while staff understood
that infection prevention and control practices reduce the risk
of transmission of potential pathogens, they were also con-
cerned about the adverse effects of these practices on individ-
ual residents, particularly depression. Extending these find-
ings, Cohen et al. found in their study of ten nursing homes
that staff expressed strong concerns about the influence of
infection prevention and control practices on residents; one
interviewee described isolation as “almost like holding a per-
son prisoner” [58••]. Efforts to improve infection prevention
and control practices in nursing homes will need to account
for the concerns and perceptions of the front line staff ulti-
mately responsible for their day-to-day implementation.
Addressing the Challenges of MDRO Prevention
and Control in Nursing Homes
Many of the MDRO prevention challenges identified above
are driven by knowledge and resource gaps in the nursing
home setting. Fortunately, a small but growing number of
studies provide evidence that specifically addresses these
challenges in nursing homes and other long-term care settings.
An emerging theme from these studies is a shift in MDRO
prevention strategies away from an approach based on the
knowledge of a resident harboring a specific pathogen and
toward an approach based on knowledge of resident risk fac-
tors for MDRO transmission and acquisition, such as the
uncontained bodily fluids and indwelling devices.
First, given the evidence of cross-contamination between
nursing home residents and caregivers, broad approaches to
reduce the reservoir for MDRO transmission might have ap-
plications in the nursing home setting. A study by Roghmann
et al. quantified the risk of MRSA contamination on the hands
and clothes of healthcare personnel during interactions with
MRSA-colonized residents [59••]. Rates of transmission in-
creased from residents with chronic skin breakdown and, no-
tably, during assistance with high-risk activities such dressing,
transferring, providing hygiene, changing linens, and toileting
(OR >1.0; P < .05). This study confirms the risk of MDRO
transmission during common caregiving activities.
Chlorhexidine bathing may be a potential strategy to help
reduce transmission by decreasing the prevalence of
MDROs among nursing home residents. At four long-term
acute care facilities in Chicago, incorporating daily chlorhex-
idine bathing used as part of a bundled intervention led to a
significant reduction of KPC colonization and infection [60•].
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The bundled intervention included rectal screening patients
for colonization with KPC, contact isolation, and geographic
separation of KPC-positive patients in ward cohorts or single
rooms and healthcare worker education and adherence moni-
toring. A similar approach may be successful in nursing
homes, as suggested by a pilot study that used chlorhexidine
bathing and nasal iodophor [61]. During the 3-month inter-
vention, the three participating nursing homes achieved a de-
crease in the prevalence of MRSA (29 to 19%), VRE (12 to
4%), and ESBL (15 to 9%).
Second, potential strategies to address the limited resources
in nursing homes may come from leveraging community and
regional resources. The interconnectedness between the acute
healthcare facilities and nursing homes suggests that coordi-
nated approaches across care settings may be needed to reduce
the burden of MDROs [62]. At a regional level, creating a
multidisciplinary task force can facilitate the standardization
of infection prevention and control guidelines, improve inter-
facility communication about MDROs during care transitions
[63], and provide infection prevention and control expertise.
The Centers for Disease Control and Prevention (CDC) re-
cently recommended a coordinated approach for the preven-
tion of MDRO and C. difficile with the involvement of health
departments, acute care hospitals, and post-acute and long-
term care settings [64]. While specific recommendations and
models for this type of multi-institutional, cooperative infec-
tion prevention and control effort are not yet available, two
examples come from the control of VRE in the Siouxland
region of Iowa, Nebraska and South Dakota and the control
of CRE in Israel healthcare facilities [65, 66]. Both prevention
efforts convened a task force comprising public health
workers and personnel from acute and long-term care facili-
ties. The task force generated guidelines for screening and
infection control and also worked to improve communication
among facilities. In the Siouxland region, the prevalence of
VRE decreased from 2.2% in 1997 to 0.5% in 1999 among 30
acute and long-term facilities [65]. In Israel, the task force
issued evidence-based guidelines in 2007 that were specific
to long-term care facilities. The guidelines supported the care
of CRE-colonized residents without compromising their abil-
ity to participate in rehabilitation and socialization important
to their well-being [66]. Furthermore, in 2014, the Illinois
Department of Public Health launched a statewide registry
of extensively drug-resistant organisms which permits bidirec-
tional, web-based exchange of information among acute care,
long-term acute care, and long-term facilities. This approach
supports regional infection prevention and control efforts and
may overcome communication gaps that occur during care
transitions [67, 68].
The third challenge is that of dedicating personnel and
education to infection prevention and control. As part of a
larger study, Koo et al. reported that didactic and interactive
educational sessions for nurses, CNAs, and environmental
service staff, repeated every 2–3 months over 3 years, im-
proved staff’s infection prevention and control knowledge
[69]. Differences in knowledge scores were noted between
nursing and CNAs highlighting the need to tailor the educa-
tion for people in different roles. Unfortunately, as predicted
by behavioral health theory [70, 71], education alone is not
sufficient to generate the sustained behavioral changes neces-
sary to reduce the risk of MDRO acquisition among nursing
home residents [72, 73]. Ho et al. described sharing a written
infection control plan with nursing home staff for activities
related to enteral feeds which successfully reduced the preva-
lence of MRSA [74]. Further studies might investigate the
correlation between hours allocated to infection prevention
and control activities, the training of the personnel performing
those activities, and the prevalence ofMDROs among nursing
home residents.
Addressing the final challenge, which is the stigmatizing
influence of isolation and contact precautions on the welfare
of nursing home residents, may require a paradigm shift.
Currently, identification of an MDRO prompts initiation of
isolation precautions. Rather than implemented as a reaction
to a specific communicable disease, transmission-based pre-
cautions could be applied proactively to nursing home resi-
dents based on their individual risk factors. This has the po-
tential to reduce the social discomfort associated with having
an MDRO as well as reduce the risk of MDRO transmission.
In 2010, the California Department of Public Health intro-
duced enhanced standard precautions for long-term care facil-
ities. Specifically, any contact with a resident with uncon-
trolled or uncontained secretions or body fluids warrants using
personal protective equipment (e.g., gloves, gowns, surgical
masks, and eye protection) [75]. Mody et al. studied a similar
approach, focusing on nursing home residents with indwelling
devices. They used a cluster randomized trial to examine
whether a multimodal-targeted infection program would re-
duce the prevalence of MDROs and incident device-related
infections [76••]. The intervention included preemptive barrier
precautions, active surveillance for several MDROs, and in-
fections with feedback about those data as well as comprehen-
sive infection prevention education to nursing home staff. For
the barrier precautions, the nursing home instructed staff to
wear gowns and gloves during the care of residents with in-
dwelling devices such as feeding tubes and urinary catheters.
The residents socialized and participated in rehabilitation out-
side of their rooms without additional precautions. The results
showed a 23% reduction in the prevalence density ofMDROs,
which included MRSA, VRE, and Gram-negative bacteria
resistant to either ciprofloxacin or ceftazidime (rate ratio
0.77, 95% CI 0.62–0.94).
While the above studies provide new paradigms for
MDRO prevention in nursing homes, additional evaluations
may be needed to address issues such as cost and resource
allocation. For example, using a prospective, observational
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approach, Roghmann et al. estimated that for community
nursing homes, the average cost of standard precautions was
$100 per resident per month, $125 per resident per month if
gowns/gloves were used for all residents with chronic skin
breakdown, but increased to $223 if gowns and gloves were
used for all high-risk care activities [77•]. The cost-analysis
highlights the importance of providing data that can help nurs-
ing homes estimate, and thus prepare for, the costs related to
new approaches to MDRO prevention and control.
Conclusions
Age, comorbid illnesses, invasive medical devices, frequent
antibiotic exposure, and dependence on healthcare workers, in
the setting of communal living, all serve to increase the risk of
nursing home residents becoming colonized or infected with
healthcare-acquired bacterial pathogens. As more medically
complex patients seek care, nursing homes need to adapt
and improve their infection prevention and control approach
and do so in a matter that facilitates staff adherence. Basing
barrier precautions on the presence of an indwelling device or
specific task, such as assistance with bathing, is much easier
for all staff members to understand and incorporate into their
workflow. Additionally, this approach may help decentralize
the responsibility for infection prevention and control from a
single individual to several staff members. Over time, a para-
digm shift to an approach based on resident risk factors may
lead to noticeable improvements in infection prevention and
control that also upholds the quality of life, comfort, and dig-
nity of older adults living in nursing homes. In addition to
improving specific nursing home infection control and pre-
vention programs, the development of collaborative efforts
across local and regional healthcare facilities will enhance
the overall success of reducing the burden of MDROs across
the continuum of care.
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